BriaCell Therapeutics
BriaCell is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer, with a focus on advanced breast cancer.
Last updated on
About BriaCell Therapeutics
Founded
2004Estimated Revenue
$1M-$10MEmployees
1-10Funding / Mkt. Cap
$27MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
VancouverState
British ColumbiaCountry
CanadaBriaCell Therapeutics
Find your buyer within BriaCell Therapeutics
Tech Stack (30)
.png)
